IPO Boutique

Protara Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Protara Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Protara Therapeutics, Inc.TARA - Last trade $6.67 $6.25 $0.00$100 million12/10/2024
TD Cowen, Cantor, LifeSci Capital, Oppenheimer, Scotiabank
Co-Manager(s):
Filing(s):




Protara Therapeutics, Inc. Quote & Chart - Click for current quote - TARA

About Protara Therapeutics, Inc. (adapted from Protara Therapeutics, Inc. prospectus):
They are committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "TARA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved